Loading candles…
NGL Fine-Chem Ltd, incorporated in 1981, operates as a manufacturer and exporter specializing in pharmaceuticals, intermediates, Active Pharmaceutical Ingredients (APIs), and finished dosage forms. The company serves both veterinary and human health sectors, with a predominant emphasis on animal health. It holds a significant position in the veterinary API market, deriving approximately 90% of its revenue from animal health products. NGL Fine-Chem Ltd employs deep backward integration, producing 95% of its raw materials in-house, which supports its cost competitiveness and quality control efforts. The company is engaged primarily in the pharmaceuticals, veterinary health, and human health industries.
This page is a live market overview for NGL FINE CHEM LIMITED (NGLFINE) on the NSE. As a listed security, NGL FINE CHEM LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NGLFINE before placing trades on tick2trade.
As of the latest feed, NGLFINE last traded at ₹3,403.6 on NSE, down ₹24.9 (0.73%) from the previous close of ₹3,428.5. Today's session range is ₹3,271 – ₹3,441, against a 52-week band of ₹1,175.5 – ₹3,448.2. Traded volume today stands at 4.62K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for NGLFINE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NGLFINE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NGL FINE CHEM LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NGLFINE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NGLFINE option chain page linked from this overview.
| Results - FY25 |
| To consider and approve the financial results for the period ended September 30, 2025 |
| 12 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 1 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.